Knowledge (XXG)

Dura Pharmaceuticals, Inc. v. Broudo

Source 📝

133: 360:
shown that the price on the date of purchase was inflated because of the misrepresentation." 339 F. 3d, at 938 (emphasis in original; internal quotation marks omitted). It added that "the injury occurs at the time of the transaction." Ibid. Since the complaint pleaded "that the price at the time of purchase was overstated," and it sufficiently identified the cause, its allegations were legally sufficient. Ibid.
24: 359:
The Court of Appeals for the Ninth Circuit reversed. In the portion of the court's decision now before us—the portion that concerns the spray device claim—the Circuit held that the complaint adequately alleged "loss causation." The Circuit wrote that "plaintiffs establish loss causation if they have
355:
The District Court dismissed the complaint. In respect to the plaintiffs' drug-profitability claim, it held that the complaint failed adequately to allege an appropriate state of mind, i.e., that defendants had acted knowingly, or the like. In respect to the plaintiffs' spray device claim, it held
461: 377: 174: 41: 363:
Because the Ninth Circuit's views about loss causation differ from those of other Circuits that have considered this issue, we granted Dura's petition for certiorari.
328:, holding that an inflated purchase price will not by itself constitute or proximately cause the relevant economic loss needed to allege and prove "loss causation." 466: 451: 347:
Respondents are individuals who bought stock in Dura Pharmaceuticals, on the public securities market between April 15, 1997, and February 24, 1998.
219:
An inflated purchase price will not by itself constitute or proximately cause the relevant economic loss needed to allege and prove "loss causation."
88: 60: 456: 67: 74: 325: 137: 107: 56: 45: 81: 397: 34: 206: 250: 381: 166: 406: 278: 242: 234: 274: 262: 388: 415: 286: 254: 445: 266: 169: 337: 23: 185: 181: 424: 433: 356:
that the complaint failed adequately to allege "loss causation."
203: 132: 17: 324:, 544 U.S. 336 (2005), is a securities fraud decision by the 462:
United States Supreme Court cases of the Rehnquist Court
307: 299: 294: 223: 213: 198: 193: 161: 156:
Dura Pharmaceuticals, Inc., et al. v. Broudo et al.
151: 144: 125: 48:. Unsourced material may be challenged and removed. 8: 122: 108:Learn how and when to remove this message 57:"Dura Pharmaceuticals, Inc. v. Broudo" 313:109 Stat. 747, 15 U.S.C. §78u-4(b)(4) 120:2005 United States Supreme Court case 7: 374:Dura Pharmaceuticals, Inc. v. Broudo 321:Dura Pharmaceuticals, Inc. v. Broudo 126:Dura Pharmaceuticals, Inc. v. Broudo 46:adding citations to reliable sources 326:Supreme Court of the United States 138:Supreme Court of the United States 14: 467:United States securities case law 452:United States Supreme Court cases 384:336 (2005) is available from: 131: 22: 33:needs additional citations for 457:2005 in United States case law 1: 303:Breyer, joined by unanimous 483: 434:Oyez (oral argument audio) 335: 312: 228: 218: 130: 145:Argued January 12, 2005 147:Decided April 19, 2005 180:125 S. Ct. 1627; 161 42:improve this article 279:Ruth Bader Ginsburg 251:Sandra Day O'Connor 351:Procedural history 239:Associate Justices 317: 316: 235:William Rehnquist 118: 117: 110: 92: 474: 438: 432: 429: 423: 420: 414: 411: 405: 402: 396: 393: 387: 224:Court membership 135: 134: 123: 113: 106: 102: 99: 93: 91: 50: 26: 18: 482: 481: 477: 476: 475: 473: 472: 471: 442: 441: 436: 430: 427: 421: 418: 412: 409: 403: 400: 394: 391: 385: 369: 353: 345: 340: 334: 277: 275:Clarence Thomas 265: 263:Anthony Kennedy 253: 243:John P. Stevens 209:(9th Cir. 2003) 189: 146: 140: 121: 114: 103: 97: 94: 51: 49: 39: 27: 12: 11: 5: 480: 478: 470: 469: 464: 459: 454: 444: 443: 440: 439: 407:Google Scholar 368: 367:External links 365: 352: 349: 344: 341: 336:Main article: 333: 330: 315: 314: 310: 309: 305: 304: 301: 297: 296: 292: 291: 290: 289: 287:Stephen Breyer 255:Antonin Scalia 240: 237: 232: 226: 225: 221: 220: 216: 215: 211: 210: 200: 196: 195: 191: 190: 179: 163: 159: 158: 153: 152:Full case name 149: 148: 142: 141: 136: 128: 127: 119: 116: 115: 30: 28: 21: 13: 10: 9: 6: 4: 3: 2: 479: 468: 465: 463: 460: 458: 455: 453: 450: 449: 447: 435: 426: 417: 408: 399: 398:CourtListener 390: 383: 379: 375: 371: 370: 366: 364: 361: 357: 350: 348: 342: 339: 331: 329: 327: 323: 322: 311: 306: 302: 298: 293: 288: 284: 280: 276: 272: 268: 264: 260: 256: 252: 248: 244: 241: 238: 236: 233: 231:Chief Justice 230: 229: 227: 222: 217: 212: 208: 205: 201: 197: 192: 187: 183: 177: 176: 171: 168: 164: 160: 157: 154: 150: 143: 139: 129: 124: 112: 109: 101: 98:February 2010 90: 87: 83: 80: 76: 73: 69: 66: 62: 59: –  58: 54: 53:Find sources: 47: 43: 37: 36: 31:This article 29: 25: 20: 19: 16: 373: 362: 358: 354: 346: 320: 319: 318: 308:Laws applied 295:Case opinion 282: 270: 267:David Souter 258: 246: 194:Case history 173: 155: 104: 95: 85: 78: 71: 64: 52: 40:Please help 35:verification 32: 15: 338:Strike suit 446:Categories 425:OpenJurist 332:Background 186:U.S. LEXIS 184:577; 2005 68:newspapers 182:L. Ed. 2d 162:Citations 372:Text of 300:Majority 389:Cornell 214:Holding 82:scholar 437:  431:  428:  422:  419:  416:Justia 413:  410:  404:  401:  395:  392:  386:  285: 283:· 281:  273: 271:· 269:  261: 259:· 257:  249: 247:· 245:  84:  77:  70:  63:  55:  380: 343:Facts 199:Prior 89:JSTOR 75:books 382:U.S. 204:F.3d 202:339 188:3478 175:more 167:U.S. 165:544 61:news 378:544 207:933 170:336 44:by 448:: 376:, 178:) 172:( 111:) 105:( 100:) 96:( 86:· 79:· 72:· 65:· 38:.

Index


verification
improve this article
adding citations to reliable sources
"Dura Pharmaceuticals, Inc. v. Broudo"
news
newspapers
books
scholar
JSTOR
Learn how and when to remove this message
Supreme Court of the United States
U.S.
336
more
L. Ed. 2d
U.S. LEXIS
F.3d
933
William Rehnquist
John P. Stevens
Sandra Day O'Connor
Antonin Scalia
Anthony Kennedy
David Souter
Clarence Thomas
Ruth Bader Ginsburg
Stephen Breyer
Supreme Court of the United States
Strike suit

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.